Toxicologic Pathologist

Req ID:  61612

S-Hertogenbosch, NL, 5231 DD

For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.


Due to a growing market demand our Pathology Department in ‘s-Hertogenbosch, The Netherlands, has a career opportunity for a TOXICOLOGIC PATHOLOGIST.

Toxicologic Pathologist

Your tasks:

  • Gross and histopathological evaluation of tissues from toxicology or target animal safety studies;
  • Author comprehensive pathology narrative reports of organ weight, gross and microscopic findings, while meeting report deadlines;
  • Supervise necropsies;
  • Exchange with pathology peers from other sites within the company worldwide and with other departments (Study Directors, Clinical Pathologist);
  • Interact with clients and external parties;
  • Participate in scientific meetings and continuing education seminars, contribute to peer-reviewed publications and conference presentations.


Your Profile:

  • DVM or equivalent with postgraduate Pathology certification, preferably ACVP or ECVP;
  • English fluency (both verbal and written);
  • Excellent communication and reporting skills;
  • Proper knowledge of and/or experience with GLP;
  • A pro-active, results-oriented, enthusiastic, dynamic and flexible attitude;
  • A team player.

Our offer:

  • A challenging job in an international team with five in-house Toxicologic Pathologists belonging to the world largest CRO pathologist community;
  • Good primary and secondary terms of employment, and open corporate culture in a pleasant and informal atmosphere;
  • The possibility to evolve and develop yourself in your area of expertise.


For more information about this job opening please contact Hetty van den Brink-Knol, Section Head Pathology (


About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market.  Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.


About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 13,000 employees within 80 facilities in 23 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges.  Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of 80% of the drugs approved by the FDA in 2019.


For more information, please visit